Last reviewed · How we verify
Persistent pulmonary hypertension of the newborn
Approved treatments
- Inomax · Vero Biotech Inc
- NITROGEN, NF · UNIVERSAL INDUSTRIAL GASES, INC
- Vasodil · Novartis
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Persistent pulmonary hypertension of the newborn patent landscape — cliff calendar, originator estates, attackable patents
- Persistent pulmonary hypertension of the newborn treatment landscape brief
- Persistent pulmonary hypertension of the newborn treatment updates RSS
Frequently asked questions about Persistent pulmonary hypertension of the newborn
What drugs treat Persistent pulmonary hypertension of the newborn?
Tracked treatments include Inomax, NITROGEN, NF, Vasodil.
What is the treatment for Persistent pulmonary hypertension of the newborn?
Standard treatment for Persistent pulmonary hypertension of the newborn includes Inomax, NITROGEN, NF, Vasodil. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Persistent pulmonary hypertension of the newborn patent cliff · Persistent pulmonary hypertension of the newborn CI report
- Treatment: Inomax · Vero Biotech Inc
- Treatment: NITROGEN, NF · UNIVERSAL INDUSTRIAL GASES, INC
- Treatment: Vasodil · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing